← All patents

US20110008368A1

Methods of modulating the ox40 receptor to treat cancer

University of Texas System

Abstract

Numerous disease states, such as human allergic, autoimmune, and autoimmune diseases, and cancer, may be treated by targeting OX40/OX4OL. OX4OL inhibits the generation of Tr1 cells from naïve and memory CD4+ T cells. This unique function of OX4OL is not shared by two other costimulatory TNF-family …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Yong-Jun Liu
Priority date
January 13, 2006
Filing date
August 23, 2010
Publication date
January 13, 2011
Language
en
Metadata fetched
August 29, 2026 00:20